Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Registry Hub
Electrolyte/Prescription

SODIUM CHLORIDE 5% IN PLASTIC CONTAINER

SODIUM CHLORIDE 5% IN PLASTIC CONTAINER

Clinical safety rating

safe

No significant drug interactions Can cause hypernatremia and fluid overload.


Mechanism of Action

Sodium chloride 5% acts as an osmotic diuretic. The hypertonic solution creates an osmotic gradient that draws water from the intracellular space into the extracellular compartment, increasing intravascular volume and promoting free water clearance. It also replaces sodium and chloride deficits.

What the body does with it

MetabolismSodium and chloride are not metabolized; they are excreted primarily by the kidneys.
ExcretionSodium and chloride ions are freely filtered by the glomerulus; >90% is reabsorbed in the renal tubules under homeostatic regulation. Fractional excretion of sodium (FENa) is typically <1% in euvolemic states. Unabsorbed ions are eliminated in urine, with negligible biliary or fecal excretion.
Half-lifeThe terminal half-life of administered sodium and chloride is approximately 8–12 hours for excess free water elimination, reflecting renal clearance; for sodium ions, the half-life is highly variable and dependent on hydration status, renal function, and hormonal regulation (ADH, aldosterone). In anuric patients, half-life may extend to 24–48 hours.
Protein bindingSodium and chloride ions are not protein bound; they exist as free ions in plasma.
Volume of DistributionApproximately 0.6–0.7 L/kg, corresponding to total body water. For sodium, the Vd approximates the extracellular fluid volume (~0.2 L/kg) because sodium is primarily extracellular; chloride distributes similarly.
BioavailabilityIntravenous: 100% bioavailability. Oral: Variable; sodium and chloride are nearly completely absorbed (≥95%) via active transport and solvent drag in the small intestine.
Onset of ActionIntravenous infusion: Immediate correction of plasma volume depletion occurs within minutes; plasma sodium concentration begins to rise within 30–60 minutes of infusion start. Hypotonic hyponatremia correction: onset within 1–2 hours.
Duration of ActionIntravenous: Volume expansion effects persist for 2–6 hours depending on infusion rate, renal function, and distribution. Sodium and water redistribution continues for 12–24 hours.
Molecular Weight58.44

Classification & Brands

Dosing & administration

Intravenous infusion: 500-1000 mL as a single dose; rate varies based on patient status and indication.

Dosage formINJECTABLE
Renal impairmentContraindicated in severe renal impairment with oliguria or anuria; use with caution and monitor fluid balance in mild to moderate impairment.
Liver impairmentNo adjustment required; monitor sodium levels in patients with ascites or cirrhosis.
Pediatric useIntravenous infusion: 5-10 mL/kg/dose, administered over 2-6 hours; maximum rate 0.5-1 mEq/kg/hour.
Geriatric useUse with caution due to increased risk of fluid overload and electrolyte disturbances; consider reduced infusion rates and close monitoring.

Use during pregnancy

1st trimesterGenerally safe; used as electrolyte replenisher; monitor for fluid/electrolyte imbalance.
2nd trimesterGenerally safe; adjust dose based on maternal fluid status.
3rd trimesterGenerally safe; avoid excessive administration due to risk of fetal edema.

Clinical note

No significant drug interactions Can cause hypernatremia and fluid overload.

FDA categoryAnimal
Placental transferSodium and chloride ions cross placenta by passive diffusion; concentrations in fetal blood equilibrate with maternal levels; no known harm at physiological doses.
BreastfeedingSodium chloride is a normal constituent of breast milk; exogenous administration unlikely to affect infant; use with caution in conditions requiring sodium restriction.
Lactation RatingL1 (Safe)
Teratogenic RiskSodium chloride is a normal constituent of body fluids and is not teratogenic. No fetal risks have been associated with its administration at therapeutic doses in any trimester.
Fetal MonitoringMonitor serum electrolytes, fluid balance, and renal function during prolonged or high-volume infusion. Assess for signs of fluid overload or hypernatremia.
Fertility EffectsNo adverse effects on fertility are expected as sodium chloride is a physiological electrolyte.

Warnings & precautions

■ FDA Black Box Warning

None.

Side Effect Profile

Common Effectsfluid replacement
Serious Effects

Absolute Contraindications

HypernatremiaFluid overloadAnuriaAcute renal failure with oliguria

Clinical Precautions

PrecautionsRisk of hypernatremia and hyperosmolality, especially in patients with renal impairment or those receiving large volumes., Central pontine myelinolysis (osmotic demyelination) if hyponatremia is corrected too rapidly., Infusion reactions: phlebitis, extravasation, and hypervolemia., Use with caution in patients with heart failure, renal failure, or edema.
Food/DietaryNo specific food interactions, but patients with hyponatremia should avoid excessive water intake and adhere to any fluid restrictions prescribed. A balanced diet with appropriate sodium intake as per medical advice is recommended. Avoid high-sodium processed foods if at risk of fluid overload.

Clinical Tips & Counseling

Clinical PearlsUse with caution in patients with congestive heart failure, severe renal impairment, or hypernatremia. Monitor serum sodium levels frequently. Rapid infusion can cause fluid overload, especially in elderly or pediatric patients. In hyponatremia, correct sodium slowly (≤8-10 mEq/L per 24 hours) to avoid osmotic demyelination. Hypertonic saline (3% or higher) is preferred for severe symptomatic hyponatremia; 5% is rarely used as it is more hyperosmolar. Ensure patency of IV access and assess for signs of extravasation due to hypertonic solution.
Patient AdviceThis medication is a concentrated salt solution used to correct low sodium levels in your blood. · You may experience injection site pain or irritation; report any redness or swelling to your healthcare provider. · During treatment, you will have regular blood tests to monitor your sodium levels and kidney function. · Tell your doctor if you have a history of heart failure, kidney disease, or if you are on a low-salt diet. · Do not consume large amounts of salt in your diet unless directed by your doctor. · Seek immediate medical attention if you experience headache, nausea, confusion, or seizures, which may indicate rapid sodium correction.

SODIUM CHLORIDE 5% IN PLASTIC CONTAINER Interactions

Loading safety data…

This overview is compiled from peer-reviewed clinical sources and FDA labeling. It's here to support — not replace — clinical judgment. Always verify dosing against your institution's current protocols before prescribing.

On this page

Mechanism of ActionDosing & administrationUse during pregnancyWarnings & precautionsDrug interactions

Compare with

ACETATED RINGER'S IN PLASTIC CONTAINERACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREEAMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERAMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERAMINOPHYLLINE IN SODIUM CHLORIDE 0.45%

External sources

DailyMed (NIH) PubMed OpenFDA